UBS Group’s Liminatus Pharma, Inc. Class A Common Stock LIMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$351K Buy
+31,486
New +$351K ﹤0.01% 5112